Home › Funds › CAPITAL COUNSEL LLC/NY › GILD

CAPITAL COUNSEL LLC/NY position in GILD

GILEAD SCIENCES INC · Health Care

CAPITAL COUNSEL LLC/NY reported holding 68,928 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$10.3M, representing 0.43% of its reported portfolio and ranking #16 among its reported holdings. CAPITAL COUNSEL LLC/NY has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)68.93K sh
Reported value held$10.27M
Portfolio Weight0.43%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CAPITAL COUNSEL LLC/NY's GILD position evolved

CAPITAL COUNSEL LLC/NY first disclosed a stake in GILD in Q3 2023 at 69,310 shares (US$5.2M). The position peaked in Q3 2026 at 68,928 shares, worth US$10.3M. Across 13 filings, CAPITAL COUNSEL LLC/NY increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 68,928 shares valued at US$10.3M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 69.31K $5.19M New
Q4 2023 69.31K $5.61M Hold
Q1 2024 69.31K $5.08M Hold
Q2 2024 69.31K $4.76M Hold
Q3 2024 69.31K $5.81M Hold
Q4 2024 68.15K $6.30M Reduce
Q1 2025 68.15K $7.64M Hold
Q2 2025 69.21K $7.67M Add
Q3 2025 69.21K $7.68M Hold
Q4 2025 69.21K $8.49M Hold
Q1 2026 68.93K $9.61M Hold
Q2 2026 68.93K $8.71M Hold
Q3 2026 68.93K $10.27M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has CAPITAL COUNSEL LLC/NY held GILD?

CAPITAL COUNSEL LLC/NY has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CAPITAL COUNSEL LLC/NY's current position in GILD?

As of Q3 2026, CAPITAL COUNSEL LLC/NY holds 68.93K shares of GILD (GILEAD SCIENCES INC), valued at $10.27M, representing 0.43% of its reported portfolio and ranking #16.

Has CAPITAL COUNSEL LLC/NY been buying or selling GILD?

In the latest 13F filing (Q3 2026), CAPITAL COUNSEL LLC/NY held unchanged its position in GILD. The position peaked in Q3 2026 at 68.93K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.